Veterinary Biologicals Biobank Market

• Market Growth: The global veterinary biologicals biobank market is projected to grow from USD 155.39 million in 2024 to USD 284.06 million by 2031, at a CAGR of 9.0%, driven by increasing demand for high-quality animal-derived biological samples for research and diagnostics.

• Technological Advancements: Innovations in biobanking technologies, such as automation, cryopreservation, and Laboratory Information Management Systems (LIMS), are enhancing sample integrity, traceability, and accessibility, thereby supporting the growth of the market.

• Regional Dynamics: North America and Europe are leading the market due to well-established veterinary research infrastructure, stringent regulatory standards, and high adoption rates of advanced biobanking technologies. The Asia-Pacific region is expected to witness significant growth due to rising investments in veterinary research and development.

• Application Segmentation: Veterinary biologicals biobanks support various applications, including genetic and genomic studies, vaccine development, disease surveillance, and personalized veterinary medicine, thereby contributing to advancements in animal health and welfare.

• Ethical Considerations: Ethical issues related to sample collection, donor consent, and data privacy are critical in veterinary biobanking. Adherence to ethical guidelines and regulatory compliance is essential to maintain public trust and ensure the responsible use of biological samples.

• Market Challenges: Challenges such as limited awareness in developing regions, high operational costs, and the need for standardized protocols may impede market growth. Addressing these challenges through education, collaboration, and policy development is crucial for the sustainable expansion of the market.

• Competitive Landscape: Key players in the veterinary biologicals biobank market include Vetbiobank, Cornell Veterinary Biobank, University of Nottingham, and IZSLER, focusing on expanding their sample repositories, enhancing technological capabilities, and forming strategic partnerships to strengthen their market position.

• In June 2025, a veterinary-bio services provider launched a dedicated biobank platform for veterinary biologicals, offering long-term storage of animal DNA, serum and tissue specimens to support vaccine development, infectious-disease research and companion-animal diagnostics.

• In March 2024, a veterinary diagnostics firm entered into a strategic collaboration with a research-institute biorepository to co-develop standardized sample-collection and storage workflows, enhancing traceability and expanding access to high-quality biological specimens in the veterinary biologicals biobank market.

The Veterinary Biologicals Biobank Market has been segmented by Product, Animal, End-User, Application, and Geography. This market is gaining momentum with the expansion of veterinary genomic research and the rising need for long-term preservation of biological specimens to support animal health studies. The growth is further driven by increasing initiatives in comparative genomics, translational veterinary research, and infectious disease monitoring, as well as the growing integration of biobanking in personalized veterinary medicine.

Veterinary Biologicals Biobank Market, Segmentation by Product

The Product segment includes Frozen Biological Samples and DNA & RNA Samples. These products form the core of biobanking operations, supporting multiple research and diagnostic purposes across veterinary medicine and animal genomics.

Frozen Biological Samples

Frozen Biological Samples dominate the market, comprising tissues, plasma, serum, and whole blood stored under controlled cryogenic conditions. These samples are essential for pathogen identification, biomarker discovery, and vaccine development. Growing focus on zoonotic disease surveillance and advancements in cryopreservation techniques are fueling segment growth.

DNA & RNA Samples

DNA & RNA Samples are critical for genetic sequencing, molecular diagnostics, and comparative genomic analysis. The adoption of next-generation sequencing (NGS) and genomic screening technologies is increasing the demand for high-quality nucleic acid samples preserved under standardized conditions. This segment plays a pivotal role in hereditary disease research and selective breeding programs.

Veterinary Biologicals Biobank Market, Segmentation by Animal

The Animal segment comprises Dogs, Cats, Horses, and Others. The biobanking of animal biologicals allows researchers to study species-specific diseases, genetic diversity, and therapeutic responses.

Dogs

Dogs represent the largest segment due to their prominence in genetic research and comparative oncology. Biobanked canine samples are widely used to study cancer, cardiovascular, and metabolic disorders, making this segment a key contributor to market growth.

Cats

Cats are gaining importance for research in infectious diseases, immunology, and hereditary conditions. The rising pet population and improved diagnostics in feline medicine are boosting demand for sample collection and storage.

Horses

Horses play a significant role in the biobank ecosystem for studies related to musculoskeletal disorders, equine influenza, and genetic traits. The expansion of equine genomics and welfare-focused research programs continues to propel this category forward.

Others

The Others category includes livestock and exotic animals. Biobanking efforts for these species are crucial for zoonotic disease control and conservation biology. The growing global interest in livestock genetics and biodiversity preservation supports this segment’s expansion.

Veterinary Biologicals Biobank Market, Segmentation by End-User

The End-User segment includes Veterinary Clinics and Research Institutions. Both end-user categories rely on biobanks for sample access, standardized storage, and disease correlation studies.

Veterinary Clinics

Veterinary Clinics utilize biobanked samples to improve diagnostic accuracy and personalized treatment for companion animals. The integration of genetic profiling and biomarker analysis into clinical practices enhances precision medicine approaches in veterinary healthcare.

Research Institutions

Research Institutions hold a dominant share, serving as major repositories for animal biological materials used in disease surveillance and genetics. Increasing global collaborations and the establishment of national and regional veterinary biobanks are key growth drivers in this segment.

Veterinary Biologicals Biobank Market, Segmentation by Application

The Application segment comprises Genetic Research and Disease Studies. Both applications are fundamental to enhancing animal health, preventive medicine, and biodiversity conservation.

Genetic Research

Genetic Research dominates the market as veterinary biobanks are instrumental in genomic mapping, breed improvement, and trait analysis. Increasing adoption of DNA sequencing and molecular profiling technologies accelerates this segment’s expansion.

Disease Studies

Disease Studies involve utilizing biobanked samples to investigate pathogenesis, immune response, and epidemiological trends. The emphasis on understanding emerging zoonotic diseases and developing effective vaccines supports the strong growth of this segment.

Veterinary Biologicals Biobank Market, Segmentation by Geography

In this report, the Veterinary Biologicals Biobank Market has been segmented by Geography into five regions: North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America

North America leads the global market with well-established veterinary biobanking infrastructure and government-backed genomic research initiatives. The U.S. contributes significantly through university-led animal genomics programs and companion animal registries.

Europe

Europe maintains a strong position supported by EU-funded veterinary research projects and national biobank networks. High focus on zoonotic disease prevention and sustainable animal breeding further supports regional demand.

Asia Pacific

Asia Pacific is expected to grow rapidly due to increasing veterinary healthcare investments, expanding pet populations, and genomic innovation programs across countries such as China, Japan, and Australia. The establishment of regional animal sample repositories enhances market penetration.

Middle East & Africa

Middle East & Africa are witnessing rising adoption of biobanking for livestock genetic improvement and zoonotic disease surveillance. Collaborations with international veterinary research organizations are strengthening this region’s ecosystem.

Latin America

Latin America demonstrates steady growth, led by government-funded animal research programs and veterinary universities in Brazil, Mexico, and Argentina. Increasing focus on animal welfare and infectious disease control is driving the development of biobanking facilities.

This report provides an in depth analysis of various factors that impact the dynamics of Global Veterinary Biologicals Biobank Market. These factors include; Market Drivers, Restraints and Opportunities Analysis

Drivers, Restraints and Opportunity Analysis

Veterinary Biologicals Biobank Market is characterized by a competitive landscape where established players and emerging firms focus on strategic collaboration, targeted partnerships, and selective merger activities. More than 40% of the market is dominated by leading companies that leverage their advanced technological advancements and robust storage networks to secure a competitive edge.

Market Structure and Concentration
The market structure shows moderate concentration, with top-tier organizations holding over 35% share, supported by their extensive biobank infrastructures. Mid-sized companies emphasize expansion strategies, focusing on niche segments such as rare species. This balance ensures competitive pricing, steady growth, and stronger resource allocation across veterinary healthcare.

Brand and Channel Strategies
Companies deploy diverse strategies across offline and digital channels, with nearly 55% of activities driven by institutional collaborations. Strong branding, long-term partnerships, and integration with veterinary universities strengthen supply chains. Key players invest in brand differentiation and collaborative distribution to enhance market reach and drive consistent expansion.

Innovation Drivers and Technological Advancements
More than 60% of market competitiveness stems from ongoing innovation and cutting-edge technological advancements. Leaders emphasize cryopreservation, automated sample tracking, and AI-based data systems to ensure reliability. These innovations accelerate growth, foster strategic collaboration, and reinforce the importance of high-quality veterinary biological storage solutions.

Regional Momentum and Expansion
Regional expansion remains strong, with North America and Europe accounting for nearly 45% of the market share. Asia-Pacific exhibits rapid growth driven by government-backed partnerships and increasing awareness among veterinary institutions. Regional players invest in new facilities and strategic collaboration to compete with international leaders.

Future Outlook
The future outlook indicates sustained growth, with over 50% of firms planning to expand capacity and strengthen digital platforms. Increased innovation in storage methods, enhanced strategies for collaboration, and regional expansion will define competitive advantages. The focus on long-term partnerships positions the market for progressive advancements in veterinary biological banking.

Key players in Veterinary Biologicals Biobank Market include:

• Vetbiobank
• Cornell Veterinary Biobank
• University of Nottingham
• IZSVe (Istituto Zooprofilattico Sperimentale delle Venezie)
• CryoHoldco
• BioLife Solutions, Inc.
• Worthington Industries, Inc.
• Thermo Fisher Scientific Inc.
• Brooks Automation, Inc.
• Charter Medical Ltd.
• Cryo Bio System
• STEMCELL Technologies Inc.
• Merck KGaA (Sigma-Aldrich)
• So-Low Environmental Equipment Co.
• MARS Petcare Biobank

In this report, the profile of each market player provides following information:

• Company Overview and Product Portfolio
• Market Share Analysis
• Key Developments
• Financial Overview
• Strategies
• Company SWOT Analysis